Skip to main navigation Skip to search Skip to main content

Gender and Race as Prognostic Factors in Patients Treated with Rituximab for B-Cell Non-hodgkin Lymphoma

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalBlood / American Society of Hematology (ASH) 55th Annual Meeting
Volume122
StatePublished - Dec 2013

Disciplines

  • Medicine and Health Sciences
  • Immunology and Infectious Disease

Cite this